September 28, 2018
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
|
Re: |
JAGUAR HEALTH, INC. |
|
|
Registration Statement on Form S-1 (Registration No. 333-227292) |
|
|
Concurrence in Acceleration Request |
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the above-referenced offering, hereby concurs in the request by Jaguar Health, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Monday, October 1, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.
|
|
Very truly yours, | |
|
|
| |
|
|
H.C. WAINWRIGHT & CO., LLC | |
|
|
| |
|
|
| |
|
|
By: |
/s/ Mark Viklund |
|
|
|
Name: Mark Viklund |
|
|
|
Title: Chief Executive Officer |
430 Park Avenue | New York, New York 10022 | 212.356.0500
Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC